Compare Bundamedik Tbk (BMHS) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,520 (market cap 11.18T, 613K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 7.4× Bundamedik Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (613K versus 536.7K). Which is the better fit depends on your goals.
| BMHS | TSPC | |
|---|---|---|
Market Cap | 1.51T | 11.18T |
Volume | 536.7K | 613K |
Lot | 5.37K | 6.13K |
Turnover | 93.41M | 1.54B |
Average Price | 174.05 | 2,511.52 |
Value | 93.41M | 1.54B |
Indicative Equilibrium Price | 176 | 2,520 |
Indicative Equilibrium Volume | 100 | 17 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
